Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) are the most abundant and ubiquitous serine/threonine phosphatases in eukaryotic cells. Both enzymes are responsible for the majority of dephosphorylation of phosphoserine and phosphothreonine residues in a vast array of cellular proteins, making them crucial regulators of nearly all cellular processes, including signal transduction, the cell cycle, apoptosis, stress responses, transcription, glycogen metabolism, and more. Their enzymatic specificity and activity are achieved through assembly into multimeric holoenzymes that include various regulatory subunits, defining substrate preference and subcellular localization. Dysfunction or chemical inhibition of PP1 or PP2A has wide-ranging implications in human diseases, especially cancer, neurodegenerative and cardiovascular diseases, and is a significant therapeutic challenge due to their global regulatory roles.
Direct inhibition of the phosphatase catalytic subunit Disruption/modulation of enzyme-substrate recognition and dephosphorylation activity Modulation via regulatory subunit binding
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 and protein phosphatase 2A (PP1 and PP2A).